Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT02351037 |
Title | A Multicenter Open-Label Phase 2a Study of Ibrutinib With or Without Cytarabine in Subjects With Acute Myeloid Leukemia |
Recruitment | Terminated |
Gender | both |
Phase | Phase II |
Variant Requirements | No |
Sponsors | Pharmacyclics |
Indications | |
Therapies | |
Age Groups: | adult |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | Duarte | California | 91010 | United States | Details | |
UC Davis Medical Center | Sacramento | California | 95817 | United States | Details | |
The University of Chicago Medical Center | Chicago | Illinois | 60637 | United States | Details | |
University of Iowa | Iowa City | Iowa | 52242 | United States | Details | |
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Baltimore | Maryland | 21231 | United States | Details | |
Montefiore Einstein Center for Cancer Research | Bronx | New York | 10461 | United States | Details | |
Roswell Park Cancer Institute | Buffalo | New York | 14263 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Fred Hutchinson Cancer Research Center | Seattle | Washington | 98109 | United States | Details |